ARECOR LIMITED

Active Little Chesterford

Other research and experimental development on natural sciences and engineering

39 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
A

ARECOR LIMITED

Other research and experimental development on natural sciences and engineering

Founded 23 May 2007 Active Little Chesterford, United Kingdom 39 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 19 Jun 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 28 May 2025 Next due 5 Jun 2026 1 month remaining
Net assets £-17M £4M 2024 year on year
Total assets £3M £671K 2024 year on year
Total Liabilities £19M £4M 2024 year on year
Charges 2
1 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

Chesterford Research Park Little Chesterford Saffron Walden CB10 1XL

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ARECOR LIMITED (06256698), an active life sciences and medical technology company based in Little Chesterford, United Kingdom. Incorporated 23 May 2007. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2015–2024)

Cash in Bank

£303.00k

Decreased by £468.00k (-61%)

Net Assets

-£16.60M

Decreased by £4.29M (-35%)

Total Liabilities

£19.16M

Increased by £3.62M (+23%)

Turnover

£1.64M

Increased by £12.00k (+1%)

Employees

39

Decreased by 2 (-5%)

Debt Ratio

749%

Increased by 268 (+56%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 3

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

19 Allotments 14,997,666 Shares £6.37m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
24 May 2021123,000£1k£0.01
24 May 20216,988,575£70k£0.01
24 May 20211,221,380£12k£0.01
24 May 20214,565,910£46k£0.01
24 May 2021991,190£10k£0.01

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Arecor Therapeutics Plc
100.0%
16,668,066

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 23 Jul 2021
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Unilever Uk Holdings Limited

Ceased 9 Sept 2018

Ceased

Group Structure

Group Structure

ARECOR LIMITED Current Company

Charges

Charges

1 outstanding 1 satisfied

Properties

Properties

1 leasehold 1 total
AddressTenurePrice PaidDate Added
Building 25, Chesterford Park, Little Chesterford, Saffron Walden (CB10 1XL) UTTLESFORD
Leasehold-11 Jun 2021
Building 25, Chesterford Park, Little Chesterford, Saffron Walden (CB10 1XL)
Leasehold
Added 11 Jun 2021
District UTTLESFORD

Documents

Company Filings

DateCategoryDescriptionDocument
25 Sept 2025MortgageMortgage Create With Deed With Charge Number Charge Creation Date
19 Jun 2025AccountsAnnual accounts made up to 2024-12-31
28 May 2025Confirmation StatementConfirmation statement made on 2025-05-22 with no updates
24 Mar 2025OfficersAppointment of Mr David John Ellam as director on 2025-03-24
7 Feb 2025Persons With Significant ControlChange to Arecor Therapeutics Plc as a person with significant control on 2021-07-23
25 Sept 2025 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

19 Jun 2025 Accounts

Annual accounts made up to 2024-12-31

28 May 2025 Confirmation Statement

Confirmation statement made on 2025-05-22 with no updates

24 Mar 2025 Officers

Appointment of Mr David John Ellam as director on 2025-03-24

7 Feb 2025 Persons With Significant Control

Change to Arecor Therapeutics Plc as a person with significant control on 2021-07-23

Recent Activity

Latest Activity

Mortgage Create With Deed With Charge Number Charge Creation Date

6 months ago on 25 Sept 2025

Annual accounts made up to 2024-12-31

10 months ago on 19 Jun 2025

Confirmation statement made on 2025-05-22 with no updates

10 months ago on 28 May 2025

Appointment of Mr David John Ellam as director on 2025-03-24

1 years ago on 24 Mar 2025

Change to Arecor Therapeutics Plc as a person with significant control on 2021-07-23

1 years ago on 7 Feb 2025